Chargement en cours...
Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis
Ulcerative colitis (UC) is a chronic relapsing and remitting inflammatory bowel disease, with a characteristic leukocytic infiltration of the mucosa. Immunosuppression including anti-TNF-α therapy is a mainstay of treatment for many; however, systemic immunosuppression is not universally effective a...
Enregistré dans:
| Publié dans: | Clin Exp Gastroenterol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344414/ https://ncbi.nlm.nih.gov/pubmed/28424557 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S110547 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|